| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918406 | Radiotherapy and Oncology | 2014 | 8 Pages |
Abstract
RANV is a common therapy-related morbidity facing patients receiving HNC radiotherapy, and, for those receiving radiotherapy-alone, is associated with modifiable dose to specific CNS structures.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Esengul Kocak-Uzel, G. Brandon Gunn, Rivka R. Colen, Micheal E. Kantor, Abdallah S.R. Mohamed, Sara Schoultz-Henley, Paniyotis Mavroidis, Steven J. Frank, Adam S. Garden, Beth M. Beadle, William H. Morrison, Jack Phan, David I. Rosenthal,